Corrected - I meant leading edge.
Context re:distros mentioned:
GNOME OS: https://os.gnome.org/ KDE Linux: https://kde.org/linux/
Doubling progression-free survival (17.6 vs 7.4 months) is a large effect size for recurrent prostate cancer.
Doubling progression-free survival (17.6 vs 7.4 months) is a large effect size for recurrent prostate cancer.